Trial Profile
Randomized,Open-label,Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2011
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain
- Focus Pharmacokinetics
- 25 Aug 2011 New trial record